Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemiaM. W. Hess, Joost P.H. Drenth, Mark M. T. J. Broekman et al.|Pharmacogenetics and Genomics|2016Cited by 33